These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 18296502)

  • 21. Generation of cell lines propagating infectious prions and the isolation and characterization of cell-derived exosomes.
    Vella LJ; Hill AF
    Methods Mol Biol; 2008; 459():69-82. PubMed ID: 18576148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
    Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
    Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity.
    Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O
    Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
    Cronier S; Laude H; Peyrin JM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
    Gilch S; Nunziante M; Ertmer A; Schätzl HM
    Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
    Sakudo A; Wu G; Onodera T; Ikuta K
    Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complementarity determining regions of an anti-prion protein scFv fragment orchestrate conformation specificity and antiprion activity.
    Müller-Schiffmann A; Petsch B; Leliveld SR; Muyrers J; Salwierz A; Mangels C; Schwarzinger S; Riesner D; Stitz L; Korth C
    Mol Immunol; 2009 Feb; 46(4):532-40. PubMed ID: 18973947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion infection of differentiated neurospheres.
    Herva ME; Relaño-Ginés A; Villa A; Torres JM
    J Neurosci Methods; 2010 May; 188(2):270-5. PubMed ID: 20206206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoaffinity purification and neutralization of scrapie prions.
    Gabizon R; McKinley MP; Groth D; Westaway D; DeArmond SJ; Carlson GA; Prusiner SB
    Prog Clin Biol Res; 1989; 317():583-600. PubMed ID: 2574871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular pathogenesis in prion diseases.
    Crozet C; Beranger F; Lehmann S
    Vet Res; 2008; 39(4):44. PubMed ID: 18413130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
    Kim DH; Lee HM; Ryou C
    J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prion strain-dependent differences in conversion of mutant prion proteins in cell culture.
    Atarashi R; Sim VL; Nishida N; Caughey B; Katamine S
    J Virol; 2006 Aug; 80(16):7854-62. PubMed ID: 16873242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets.
    Bertsch U; Winklhofer KF; Hirschberger T; Bieschke J; Weber P; Hartl FU; Tavan P; Tatzelt J; Kretzschmar HA; Giese A
    J Virol; 2005 Jun; 79(12):7785-91. PubMed ID: 15919931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death.
    Cronier S; Carimalo J; Schaeffer B; Jaumain E; Béringue V; Miquel MC; Laude H; Peyrin JM
    FASEB J; 2012 Sep; 26(9):3854-61. PubMed ID: 22661006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generating recombinant C-terminal prion protein fragments of exact native sequence.
    Johanssen VA; Barnham KJ; Masters CL; Hill AF; Collins SJ
    Neurochem Int; 2012 Feb; 60(3):318-26. PubMed ID: 22197912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMR solution structure and SRP54M predicted interaction of the N-terminal sequence (1-30) of the ovine Doppel protein.
    Pimenta J; Viegas A; Sardinha J; Martins IC; Cabrita EJ; Fontes CM; Prates JA; Pereira RM
    Peptides; 2013 Nov; 49():32-40. PubMed ID: 23973967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
    Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
    J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decrease of Protease-Resistant PrP
    Waqas M; Trinh H; Lee S; Kim DH; Lee SY; Choe KK; Ryou C
    J Microbiol Biotechnol; 2018 Dec; 28(12):2141-2144. PubMed ID: 30394046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxicity of prion protein-derived cell-penetrating peptides is modulated by pH but independent of amyloid formation.
    Mukundan V; Maksoudian C; Vogel MC; Chehade I; Katsiotis MS; Alhassan SM; Magzoub M
    Arch Biochem Biophys; 2017 Jan; 613():31-42. PubMed ID: 27818203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.